Dr. Reddy's to Release Q2 and Half Year FY13 Results on October 30, 2012

Before you go, we thought you'd like these...
Before you go close icon

Dr. Reddy's to Release Q2 and Half Year FY13 Results on October 30, 2012

Earnings call slated for October 30, 6.30 PM IST / 9.00 AM EDT*

HYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddy's Laboratories (NYS: RDY) will announce results for the Second Quarter and Half Year ended September 30, 2012 on Tuesday, October 30, 2012 after the Board Meeting. The results will be available on the Company's website www.drreddys.com


Summary of Events

Event Date and Time (IST) Medium
Release of financial results Oct 30th, after the Board Meeting 

Email, Media, Company website, Business Wire

Earnings Call Oct 30th, 6.30 PM IST / 9:00 AM EDT 

Hosted by the Company (Details below)

 

Webcast of Earnings Call Oct 30th, 6.30 PM IST / 9.00 AM EDT through Nov 4th, 2012 

URL available on Company's website, www.drreddys.com

 

Transcripts of the Earnings call Will be available on the Company's website 

URL available on Company's website, www.drreddys.com

  

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company's financial performance.

Conference Dial-In Numbers
Primary Number: +91 22 3065 0136
Secondary Number: +91 22 6629 0356
The numbers listed above are universally accessible from all networks and all countries.
Local Access Number: 

6000 1221
Available in - Ahmedabad, Bangalore, Chennai, Cochin, Delhi (NCR), Hyderabad, Kolkata, Lucknow

Accessible from all major carriers except BSNL/MTNL.

3940 3977
Available in Ahmedabad, Bangalore, Chandigarh, Chennai, Cochin, Gurgaon (NCR), Hyderabad, Kolkata, Lucknow, Pune


Accessible from all carriers.

International Toll Free Number: USA: 1 866 746 2133

UK: 0 808 101 1573

Singapore: 800 101 2045

Hong Kong: 800 964 448

 

No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through Nov 4th, 2012. For play back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's website.

About Dr. Reddy's

Dr. Reddy's Laboratories Ltd. (NYS: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs. Therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management, anti-infective and pediatrics. Major markets include India, USA, Russia and CIS, Germany, UK, Venezuela, S. Africa, Romania, and New Zealand. For more information, log on to: www.drreddys.com

*EDT- Eastern Daylight Time



Dr. Reddy's Laboratories
Investor Relations:
Kedar Upadhye, +91 40 66834297
kedaru@drreddys.com
or
Saunak Savla, +91 40 49002135
saunaks@drreddys.com
or
Milan Kalawadia (USA), +1 9082034931
mkalawadia@drreddys.com

KEYWORDS:   United States  Asia Pacific  North America  New York  India

INDUSTRY KEYWORDS:

The article Dr. Reddy's to Release Q2 and Half Year FY13 Results on October 30, 2012 originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners